News

This year was difficult for all of us, personally and collectively. The COVID-19 pandemic transformed every aspect of our lives and called for us to adapt in unprecedented ways. It was gratifying – yet not surprising – to see how the UCSF community met the challenges of 2020. In cancer, our care

Byron C. Hann, MD, PhD, Research Scientist and Manager of the Preclinical Therapeutics Core at the Helen Diller Family Comprehensive Cancer Center will be retiring at the end of the month. Since his arrival in 1984, Dr. Hann has collaborated with UCSF's best and brightest scientists and helped to

The University of California’s two nationally ranked medical centers, UC San Francisco and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and

A national study evaluating a personalized approach to breast cancer screening and risk assessment has launched a new effort to diversify its participants, as it hits a milestone of 30,000 women enrolled. The multiyear WISDOM study (Women Informed to Screen Depending on Measures of risk), led by UC

For 40 years, Christine Miaskowksi, RN, PhD, FAAN, has been investigating the causes of- and solutions for the debilitating side effects of cancer treatment. In recognition of her contributions as a nurse scientist, Miaskowski recently received one of nursing’s pre-eminent awards. Below, Miaskowski

More than four years after a diagnosis of glioblastoma (GBM), Susan Sandler shares her experience of living with the challenges of brain cancer.She chronicles her personal journey and revelations in her newly published book, a collection of essays titled When I First Found Out I Had Cancer. Susan